PAI
Palo Alto Investors Portfolio holdings
AUM $470M
1-Year Return
2.57%
This Quarter Return
+15.71%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.12B
AUM Growth
+$363M
(+21%)
Cap. Flow
+$173M
Cap. Flow
% of AUM
8.18%
Top 10 Holdings %
Top 10 Hldgs %
72.29%
Holding
40
New
2
Increased
23
Reduced
1
Closed
1
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$38M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$37.1M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
+$30.1M |
| 4 |
Align Technology
ALGN
|
+$21.2M |
| 5 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
+$17.3M |
Top Sells
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$33.4M |
| 2 |
Precigen
PGEN
|
+$7.47K |
Sector Composition
| 1 | Healthcare | 95.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$18.3B
| $255M | 12.05% |
1,883,315
+14,500
| +0.8% | +$1.96M |
|
|
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
| $248M | 11.72% |
3,894,963
+90,875
| +2% | +$5.79M |
|
|
ABMD
3
DELISTED
Abiomed Inc
ABMD
| $241M | 11.37% |
1,921,484
+17,900
| +0.9% | +$2.24M |
|
|
4
BioMarin Pharmaceuticals
BMRN
$10.4B
| $209M | 9.89% |
2,382,619
+422,400
| +22% | +$37.1M |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $125M | 5.89% |
1,027,060
+313,318
| +44% | +$38M |
|
|
ZLTQ
6
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $113M | 5.34% |
2,032,692
+311,929
| +18% | +$17.3M |
|
7
Insmed
INSM
$30.5B
| $96.9M | 4.58% |
5,534,150
+87,634
| +2% | +$1.53M |
|
|
EPZM
8
DELISTED
Epizyme, Inc
EPZM
| $82.2M | 3.88% |
4,791,051
+1,755,255
| +58% | +$30.1M |
|
|
WMGI
9
DELISTED
Wright Medical Group Inc
WMGI
| $81.8M | 3.87% |
2,628,193
+23,600
| +0.9% | +$734K |
|
|
SAGE
10
DELISTED
Sage Therapeutics
SAGE
| $78.3M | 3.7% |
1,101,951
+92,021
| +9% | +$6.54M |
|
|
AMAG
11
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $75.4M | 3.56% |
3,344,620
| – | – |
|
12
Prothena Corp
PRTA
$435M
| $58.9M | 2.78% |
1,055,855
+62,000
| +6% | +$3.46M |
|
13
Vanda Pharmaceuticals
VNDA
$261M
| $58.8M | 2.78% |
4,203,270
| – | – |
|
14
Amicus Therapeutics
FOLD
$2.44B
| $56.2M | 2.66% |
7,882,988
+1,472,958
| +23% | +$10.5M |
|
15
Acadia Pharmaceuticals
ACAD
$4.09B
| $54.7M | 2.58% |
1,590,430
+58,400
| +4% | +$2.01M |
|
16
Karyopharm Therapeutics
KPTI
$53.2M
| $43.7M | 2.07% |
227,098
+13,738
| +6% | +$2.65M |
|
|
CELG
17
DELISTED
Celgene Corp
CELG
| $36.7M | 1.74% |
295,240
| – | – |
|
18
STAAR Surgical
STAA
$1.35B
| $34M | 1.61% |
3,473,170
+86,925
| +3% | +$852K |
|
|
19
Align Technology
ALGN
$9.41B
| $25.6M | 1.21% |
223,107
+184,400
| +476% | +$21.2M |
|
|
AIMT
20
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $25.5M | 1.21% |
1,173,498
+793,771
| +209% | +$17.2M |
|
21
Gilead Sciences
GILD
$139B
| $23.9M | 1.13% |
351,600
+33,200
| +10% | +$2.25M |
|
|
MNTA
22
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $23.5M | 1.11% |
1,759,376
+31,996
| +2% | +$427K |
|
|
SHPG
23
DELISTED
Shire pic
SHPG
| $22.7M | 1.07% |
130,200
+6,100
| +5% | +$1.06M |
|
24
Rigel Pharmaceuticals
RIGL
$617M
| $14.1M | 0.67% |
425,462
+7,800
| +2% | +$258K |
|
25
Exact Sciences
EXAS
$9.94B
| $10M | 0.47% |
425,276
+28,300
| +7% | +$668K |
|